Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

JALAL M ABBAS

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1205895034
CMS profile
9721
Location
SUN CITY WEST, AZ

General Payments · PY2018–2024

$10,587.76

  • Reported across 235 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$2,482.99

36 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Travel and Lodging $1,679.99 16
Food and Beverage $803.00 20

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Eli Lilly and Company $2,405.73 34
Acerta Pharma LLC $77.26 2

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $1,264.44 93
PY2019 $2,611.03 59
PY2020 $252.09 18
PY2022 $1,750.24 14
PY2023 $2,226.97 15
PY2024 $2,482.99 36

Payment records · PY2024 (36)

Sorted by paying entity, then date · as published by CMS

Program year 2024 20182019202020222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $17.19 05/29/2024 Food and Beverage Undisputed 01/23/2026 1104299230 CMS
AstraZeneca Pharmaceuticals LP $60.07 05/29/2024 Travel and Lodging Undisputed 01/23/2026 1104331684 CMS
Eli Lilly and Company $7.35 04/25/2024 Travel and Lodging Undisputed 01/23/2026 1134990294 CMS
Eli Lilly and Company $105.31 04/25/2024 Food and Beverage Undisputed 01/23/2026 1134990296 CMS
Eli Lilly and Company $16.32 04/25/2024 Food and Beverage Undisputed 01/23/2026 1135016344 CMS
Eli Lilly and Company $59.86 04/25/2024 Food and Beverage Undisputed 01/23/2026 1135016346 CMS
Eli Lilly and Company $34.69 04/25/2024 Food and Beverage Undisputed 01/23/2026 1135016754 CMS
Eli Lilly and Company $59.86 04/25/2024 Food and Beverage Undisputed 01/23/2026 1135016756 CMS
Eli Lilly and Company $95.00 04/25/2024 Travel and Lodging Undisputed 01/23/2026 1135018750 CMS
Eli Lilly and Company $105.00 04/25/2024 Travel and Lodging Undisputed 01/23/2026 1135018752 CMS
Eli Lilly and Company $54.75 04/25/2024 Food and Beverage Undisputed 01/23/2026 1135018754 CMS
Eli Lilly and Company $179.00 04/25/2024 Travel and Lodging Undisputed 01/23/2026 1135035638 CMS
Eli Lilly and Company $24.81 04/25/2024 Food and Beverage Undisputed 01/23/2026 1135035646 CMS
Eli Lilly and Company $21.02 04/25/2024 Travel and Lodging Undisputed 01/23/2026 1135035740 CMS
Eli Lilly and Company $7.16 04/25/2024 Travel and Lodging Undisputed 01/23/2026 1135035744 CMS
Eli Lilly and Company $251.10 04/25/2024 Travel and Lodging Undisputed 01/23/2026 1135040539 CMS
Eli Lilly and Company $34.69 04/25/2024 Food and Beverage Undisputed 01/23/2026 1135040541 CMS
Eli Lilly and Company $5.40 04/25/2024 Food and Beverage Undisputed 01/23/2026 1135040543 CMS
Eli Lilly and Company $24.81 04/25/2024 Food and Beverage Undisputed 01/23/2026 1135040545 CMS
Eli Lilly and Company $12.81 04/25/2024 Travel and Lodging Undisputed 01/23/2026 1135041631 CMS
Eli Lilly and Company $24.81 04/25/2024 Food and Beverage Undisputed 01/23/2026 1135041645 CMS
Eli Lilly and Company $24.81 04/25/2024 Food and Beverage Undisputed 01/23/2026 1135041647 CMS
Eli Lilly and Company $14.12 06/17/2024 Food and Beverage Undisputed 01/23/2026 1135016340 CMS
Eli Lilly and Company $42.98 06/17/2024 Travel and Lodging Undisputed 01/23/2026 1135016750 CMS
Eli Lilly and Company $339.00 06/17/2024 Travel and Lodging Undisputed 01/23/2026 1135018748 CMS
Eli Lilly and Company $51.79 06/17/2024 Food and Beverage Undisputed 01/23/2026 1135035640 CMS
Eli Lilly and Company $175.00 06/17/2024 Travel and Lodging Undisputed 01/23/2026 1135040527 CMS
Eli Lilly and Company $118.73 06/17/2024 Food and Beverage Undisputed 01/23/2026 1135040529 CMS
Eli Lilly and Company $14.12 06/17/2024 Food and Beverage Undisputed 01/23/2026 1135040531 CMS
Eli Lilly and Company $32.96 06/17/2024 Food and Beverage Undisputed 01/23/2026 1135040533 CMS
Eli Lilly and Company $15.00 06/17/2024 Travel and Lodging Undisputed 01/23/2026 1135040535 CMS
Eli Lilly and Company $51.01 06/17/2024 Food and Beverage Undisputed 01/23/2026 1135041633 CMS
Eli Lilly and Company $17.50 06/17/2024 Travel and Lodging Undisputed 01/23/2026 1135041635 CMS
Eli Lilly and Company $32.96 06/17/2024 Food and Beverage Undisputed 01/23/2026 1135041637 CMS
Eli Lilly and Company $32.00 06/17/2024 Travel and Lodging Undisputed 01/23/2026 1135041639 CMS
Eli Lilly and Company $320.00 06/17/2024 Travel and Lodging Undisputed 01/23/2026 1135041641 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.